Liom secures $25 million to advance its non-invasive glucose monitoring device
Formerly known as Spiden, Liom is pioneering the development of the world’s first non-invasive glucose-monitoring wearable providing accurate glucose measurements. The company has secured $25 million in an ongoing series A funding round to develop and test the device, aiming for a pre-launch in early 2026.
Read More from the Global Wellness News ™